Legion Metals Corp Stock Canadian Securities Exchange
Equities
CA52490L1013
Pharmaceuticals
Sales 2022 | 4.41M 3.22M | Sales 2023 | 8.18M 5.98M | Capitalization | 9.67M 7.07M |
---|---|---|---|---|---|
Net income 2022 | -3M -2.19M | Net income 2023 | - 0 | EV / Sales 2022 | 2.66 x |
Net Debt 2022 | 985K 720K | Net cash position 2023 | 409K 299K | EV / Sales 2023 | 1.13 x |
P/E ratio 2022 |
-2.5
x | P/E ratio 2023 |
41
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 94.84% |
Managers | Title | Age | Since |
---|---|---|---|
Emma Andrews
CEO | Chief Executive Officer | - | 18-05-31 |
Sam Kassem
DFI | Director of Finance/CFO | - | 22-05-30 |
Catherine Marion
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Fred Bonner
BRD | Director/Board Member | 62 | 19-03-13 |
Emma Andrews
CEO | Chief Executive Officer | - | 18-05-31 |
Sherry Boodram
BRD | Director/Board Member | - | 19-10-15 |
1st Jan change | Capi. | |
---|---|---|
+25.83% | 653B | |
+27.00% | 556B | |
-6.76% | 354B | |
+20.34% | 331B | |
+3.00% | 296B | |
+13.09% | 233B | |
+5.46% | 201B | |
-9.61% | 193B | |
-6.26% | 144B |